Organisms with identical genome sequences can show substantial differences in their phenotypes owing to epigenetic changes that result in different use of their genes. Epigenetic regulation of gene expression plays a key role in the control of several fundamental processes in the biology of malaria parasites, including antigenic variation and sexual differentiation, among others. Some of the histone modifications and chromatin modifying enzymes that control the epigenetic states of malaria genes have been characterized, and their functions are beginning to be unraveled. The fundamental principles of epigenetic regulation of gene expression appear to be conserved between malaria parasites and model eukaryotes, but important peculiarities exist. Here we review the current knowledge of malaria epigenetics and discuss how it can be exploited for the development of new molecular markers and new types of drugs that may contribute to malaria eradication efforts.
ABSTRACT
Organisms with identical genome sequences can show substantial differences in their phenotypes owing to epigenetic changes that result in different use of their genes. Epigenetic regulation of gene expression plays a key role in the control of several fundamental processes in the biology of malaria parasites, including antigenic variation and sexual differentiation, among others. Some of the histone modifications and chromatin modifying enzymes that control the epigenetic states of malaria genes have been characterized, and their functions are beginning to be unraveled. The fundamental principles of epigenetic regulation of gene expression appear to be conserved between malaria parasites and model eukaryotes, but important peculiarities exist. Here we review the current knowledge of malaria epigenetics and discuss how it can be exploited for the development of new molecular markers and new types of drugs that may contribute to malaria eradication efforts.
INTRODUCTION
Epigenetic regulation of gene expression refers to heritable changes in transcription that occur in the absence of alterations in the primary sequence of DNA. Numerous important biological pathways in eukaryotes involve epigenetic regulation, both in health and during disease. Chromatin is the main platform where epigenetic processes take place, such that epigenetic traits are typically mediated by DNA modifications (such as methylation) or by changes in chromatin structure such as histone post-translational modifications or use of histone variants. In fact, there is an accepted "relaxed" use of the term epigenetics that includes all chromatin-based processes that affect transcription, regardless of whether or not information is transmitted through cell division.
In malaria parasites, epigenetic regulation of gene expression has been extensively studied only in Plasmodium falciparum. For many years, studying epigenetics in this parasite was almost synonymous to studying the regulation of var genes, which are important for antigenic variation and virulence (Kyes et al. 2001 ). However, recent findings have revealed a more general role for epigenetics in malaria parasite biology, including processes as diverse as erythrocyte invasion, solute transport, or formation of sexual forms necessary for human-to-mosquito transmission. The contribution of epigenetic regulation of gene expression to these processes stems from the clonally variant expression of some of the genes involved. Silencing of clonally variant genes, which is a process truly controlled at the epigenetic level , generally depends on histone modifications that result in reversible formation of repressive chromatin structures (heterochromatin), but several additional layers of regulation operate specifically on particular gene families such as var genes.
Genome-wide studies of heterochromatin marks or transcriptional variation identified many genes regulated at the epigenetic level that are not involved in the processes mentioned above, indicating that epigenetic regulation of gene expression plays a role in the control of other as yet uncharacterized biological processes (Lopez-Rubio et al. 2009; Flueck et al. 2009; Rovira-Graells et al. 2012 ).
Years to come will reveal the biological significance of epigenetic regulation of these genes. In all cases, epigenetic changes are likely to imply translating the same genome into alternative transcriptomes and phenotypes, increasing the plasticity of parasite populations and favoring their survival.
PROCESSES REGULATED AT THE EPIGENETIC LEVEL IN MALARIA

PARASITES
Numerous P. falciparum genes involved in host-parasite interactions show clonally variant expression, such that they are expressed in some individual parasites but not in others that are genetically identical (Table 1) . The active or silenced states of these genes are clonally transmitted during asexual replication, with switches between the two states occurring at low frequencies. The predicted functions for clonally variant genes suggest that transcriptional variation results in both antigenic and functional differences at several stages along the parasite's life cycle ( Fig. 1 ), but the phenotypic alterations associated with changes in the expression of specific clonally variant genes have been elucidated in only a few cases. In this section we describe the known processes in which epigenetic changes determine alternative phenotypes. A common theme is that for processes in which the parasite requires alternative operational states to adapt to changes in its environment or to evade host immune responses, alternative epigenetic states exist for some of the genes linked to the process.
Antigenic variation and cytoadherence
Observations of both human and animal infections clearly demonstrate that malaria parasites are capable of maintaining persistent, chronic infections for extended periods of time, even in the presence of a robust antibody response of the infected host. In experimental human infections, parasites have been observed to persist for over a year, frequently displaying characteristic waves of parasites reminiscent of similar population dynamics displayed by other infectious organisms including African trypanosomes (Miller et al. 1994 ). Thus it is clear that malaria parasites are capable of systematic antigenic variation that results in immune evasion, presumably through alterations made to proteins displayed on the surface of infected erythrocytes. In the case of P. falciparum, the formation of knobs on the infected erythrocyte membrane as well as the induction of cytoadherent properties of infected cells provided additional evidence for the placement of antigenically variant molecules on the infected cell surface (Miller et al. 2002) . The variant surface properties of the infected erythrocytes was linked to epigenetic regulation of gene expression with the discovery and description in P. falciparum of the var multi-copy gene family and the multitude of alternative forms of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) that it encodes (Smith et al. 1995; Baruch et al. 1995; Su et al. 1995) .
Individual parasites typically express only one var gene at a time, a pattern known as mutually exclusive expression that operates on top of clonal variation and results in a single form of PfEMP1 on the erythrocyte surface. All variants of PfEMP1 include a single transmembrane domain that passes through the erythrocyte membrane, thus anchoring a long, hyper-variable portion of the protein that binds to endothelial surface receptors and thereby mediates cytoadhesion.
Cytoadhesion of infected erythrocytes effectively removes them from the peripheral circulation, a phenomenon referred to as sequestration, thereby enabling them to avoid passage through the spleen where they would be detected and destroyed.
The different forms of PfEMP1 display different binding specificities, utilizing alternative host endothelial surface ligands for adhesion. This results in parasitized erythrocytes sequestering within different host tissues depending on which var gene (and the encoded form of PfEMP1) is expressed (Montgomery et al. 2007 ).
Sequestration within the brain or the placenta have been directly linked to cerebral malaria and pregnancy-associated malaria respectively, thus making PfEMP1 the best characterized virulence factor of malaria caused by P. falciparum. PfEMP1 also mediates rosetting, the binding of infected to non-infected erythrocytes that is also associated with virulence (Miller et al. 2002) .
With the availability of complete genome sequences for several Plasmodium species infecting both primates and rodents, it has become possible to catalogue the many multi-copy gene families found within these genomes. Gene families encoding variant surface proteins have been discovered in multiple Plasmodium species, suggesting that this is a universal characteristic of malaria parasites.
While some of these gene families are conserved throughout the Plasmodium lineage, others appear to be species specific. In addition to the var gene family, which includes approximately 60 members per haploid genome, P. falciparum also possesses several other large, multi-copy gene families likely involved in antigenic variation. These include the rif/stevor/Pfmc-2tm (~200 copies) and the surfins (~10 copies) (Weber 1988; Kyes et al. 1999; Sam-Yellowe et al. 2004; Winter et al. 2005 ). The largest multi-copy gene family in P. vivax is referred to as vir (~350 copies) (del Portillo et al. 2001 ), which appears to have orthologous gene families in the primate parasite P. knowlesi (kir) and in the rodent parasites P. berghei (bir), P. yoelii (yir) and P. chabaudi (cir) (Fischer et al. 2003; Janssen et al. 2004) and is also likely a distant orthologue of the rif genes of P. falciparum (Janssen et al. 2004) . P. knowlesi also possesses the sica-var family (~100 copies) which encodes a protein linked to cytoadherence similar to PfEMP1 (al-Khedery et al. 1999 ). In all cases, expression is limited to one or a limited subset of the members of each gene family at any given time. Activation and silencing of the genes of these families, as well as switching expression between members, are all thought to be regulated epigenetically.
Erythrocyte invasion
Invasion of erythrocytes is an essential step of the asexual cycle of malaria parasites. After schizonts burst, merozoites are released into the blood stream and quickly invade new erythrocytes to start a new cycle of replication. Erythrocyte invasion involves several differentiated steps, starting with initial contact, followed by merozoite reorientation and apical attachment that lead to the formation of a moving junction that progresses until the merozoite is internalized (Wright and Rayner 2014; Weiss et al. 2015) . The small eba and Pfrh gene families, each including 4-5 members, encode adhesins that are released from apical organelles and interact with erythrocyte receptors to mediate merozoite reorientation / apical attachment. Of note, merozoites can use alternative pathways for this step of invasion, each involving a different set of erythrocyte receptors. With the exception of Pfrh5, the genes of the eba and Pfrh families are non-essential and appear to be functionally redundant (Reed et al. 2000; Maier et al. 2003; Duraisingh et al. 2003; Stubbs et al. 2005; Wright and Rayner 2014) . As expected from the existence of alternative invasion pathways and the non-essentiality of these genes, several eba and Pfrh genes are spontaneously silenced in some parasite lines, and clonally variant expression mediated by epigenetic mechanisms has been directly demonstrated in some cases (Taylor et al. 2002; Duraisingh et al. 2003; Cortés et al. 2007; Jiang et al. 2010; Crowley et al. 2011) . Importantly, variant expression of invasion adhesins has also been observed in field isolates (Cortés 2008; GomezEscobar et al. 2010) . While the relation between eba and Pfrh expression patterns and the use of specific invasion pathways is complex and not completely understood, it is generally accepted that changes in the expression of these genes lead to phenotypic variation in the process of invasion Cortés 2008; Wright and Rayner 2014) . The proteins encoded by some members of the variantly expressed large multigene families rif, stevor and surfin discussed above also appear to be expressed in merozoites (Chan et al. 2014 However, the phenotypic differences resulting from the alternative transcriptional states of mspdbl2 remain unknown.
Infected erythrocyte permeability
The transport of many solutes across the infected erythrocyte membranes is mediated by the plasmodial surface anion channel (PSAC), a broad selectivity channel with several unusual transport properties (Desai 2014) . Recent research has established that the product of the parasite genes clag3.1 or clag3.2 is required for the formation of functional PSAC and efficient nutrient acquisition (Nguitragool et al. 2011; Pillai et al. 2012) . This was an unexpected finding because these genes were previously thought to participate in either cytoadherence or erythrocyte invasion .
The link between solute uptake and epigenetics comes from studies demonstrating that clag3 genes show clonally variant expression regulated at the epigenetic level (Cortés et al. 2007; Comeaux et al. 2011; Crowley et al. 2011) .
Interestingly, clag3 genes generally show mutually exclusive expression, such that individual parasites express either clag3.1 or clag3.2 (Cortés et al. 2007 ).
However, it appears to not be strict, with occasional parasites escaping mutual exclusion (Rovira-Graells et al. 2015) . While the driving force for the epigenetic regulation of the expression of clag3 genes remains unclear, it is reasonable to hypothesize that expression of alternative clag3 genes may result in different solute transport phenotypes, which may play a role in the adaptation of the parasite to varying concentrations of nutrients and other solutes in the host plasma. This might explain why mutually exclusive expression need not be strict, since silencing or expressing both genes simultaneously could provide additional phenotypic plasticity to parasite populations. In support of this view, challenging P. falciparum cultures with the toxic compound blasticidin S, which requires the PSAC for transport across the infected erythrocyte membrane, results in selection of parasites with dramatic switches in clag3 expression (Sharma et al. 2013; MiraMartínez et al. 2013) . This is indicative of a role for clag3 epigenetic regulation in the tradeoff between excluding toxic compounds from infected erythrocytes and allowing the entrance of nutrients necessary for normal growth. These results also show that switches in clag3 expression constitute a novel anti-malarial drug resistance mechanism controlled at the epigenetic level. Last, CLAG3 proteins are exposed on the erythrocyte surface (Nguitragool et al. 2011) , so in addition to influencing solute transport, switches in the expression of clag3 genes may also play a role in antigenic variation and immune evasion.
Sexual conversion
The complex life cycle of malaria parasites includes multiple welldifferentiated stages through which the parasite progresses in an ordered manner.
The single developmental decision for the parasite occurs during asexual growth in the blood stream: at each cycle of replication the parasite makes a choice between continuing asexual multiplication, as the majority of parasites do, or irreversibly converting into male or female gametocytes, which are the sexual forms of the parasite necessary for transmission to another host via a mosquito vector (Fig. 1) .
Genome-wide studies on transcriptional variation and epigenomic studies identified a member of the ApiAP2 family of transcriptional regulators that shows clonally variant expression (Rovira-Graells et al. 2012 ) and carries epigenetic marks of silencing (Lopez-Rubio et al. 2009; Flueck et al. 2009 ). The characterization of this transcriptional regulator, termed PfAP2-G, revealed that it plays an essential role in triggering sexual differentiation, such that the gene is by default silenced by heterochromatin-based epigenetic mechanisms, and only the few parasites in which the gene is stochastically activated convert into gametocytes . These results raised the idea that sexual conversion is regulated at the epigenetic level, a view that was later corroborated by studies in which specific epigenetic factors were depleted (Brancucci et al. 2014; Coleman et al. 2014) . The ortholog of pfap2-g in the distantly related murine malaria parasite P. berghei, pbap2-g, also plays a key role in gametocyte formation (Sinha et al. 2014 ). This observation suggests that ap2-g is a conserved regulator of sexual conversion in malaria parasites; whether or not epigenetic control of the process is a conserved feature in all Plasmodium species awaits experimental confirmation.
The proportion of parasites that convert into sexual forms varies among isogenic parasite subclones . Spontaneous sexual conversion rates in these subclones are stable, indicating that as yet uncharacterized epigenetic mechanisms transmit the probability of pfap2-g activation and subsequent sexual conversion. Additionally, sexual conversion rates are affected by some environmental conditions (Bousema and Drakeley 2011) , which opens up exciting perspectives about the possibility that environmental cues influence pfap2-g epigenetic states. This would provide one of the first examples in malaria of the parasite sensing the state of its host and producing a directed transcriptional response.
Epigenetic variation and adaptation to environmental changes: bet-hedging
Clonally variant expression is an intrinsic property of many P. falciparum gene families involved in disparate cellular processes (Rovira-Graells et al. 2012 ).
This implies that isogenic parasite populations spontaneously become transcriptionally heterogeneous during normal growth, such that different individual parasites have different combinations of active and epigenetically-silenced genes.
This diversity confers plasticity to parasite populations, because it provides the grounds for dynamic natural selection of parasites with highest fitness as changes in the environment occur. Adaptive strategies based on the stochastic generation of phenotypic diversity within populations before any challenge occurs, as opposed to directed adaptive responses, are commonly referred to as bet-hedging (Veening et al. 2008; Simons 2011 ).
The high level of spontaneous transcriptional diversity observed within isogenic parasite populations and the apparently stochastic nature of expression switches in clonally variant genes support the view that malaria parasites commonly use bet-hedging adaptive strategies (Rovira-Graells et al. 2012 ). This idea is also supported by the proposed limited ability of P. falciparum to adapt via directed transcriptional responses (Le Roch et al. 2008; Ganesan et al. 2008) , although this remains controversial ). In addition to the processes described above in which epigenetic changes can be ascribed to alterations in specific phenotypes, the predicted functions of some of the clonally variant genes identified (Table 1) make it tempting to speculate that they modulate fitness in front of the majority of conditions that commonly fluctuate in the human blood, which is the environment where P. falciparum asexual stages reside.
However, altogether there are few examples of well-defined adaptive pathways to specific challenges via bet-hedging in malaria, so it is still unclear whether epigenetic variation and bet-hedging play a general role in the adaptation of malaria parasite populations to changes in their environment. More experimental insight into the association between epigenetic diversity and long-term fitness in natural environments, and the identification of the clonally variant genes that mediate adaptation to specific changes in the parasite environment, are clearly needed to determine the actual contribution of bet-hedging to malarial adaptation.
EPIGENETIC MECHANISMS IN PLASMODIUM FALCIPARUM
Given the important role that epigenetic regulation of gene expression plays in the biology of malaria parasites, considerable work has focused on determining the molecular mechanisms that underlie these processes. The lion's share of this work has been performed with P. falciparum, although additional work has also been done in the rodent models of malaria. In this section we summarize recent studies that shed light on the molecular basis for epigenetic regulation in P.
falciparum.
Chromatin structure across the life cycle As mentioned briefly above, epigenetic regulation of gene expression involves heritable modifications to the way the genome is packaged that influence gene activation and silencing. Many of these modifications occur on histones, the protein subunits that comprise the nucleosomes around which the DNA strands of the chromosomes are wrapped. Modifications that increase the affinity of the histones to the DNA, thereby resulting in a more condensed chromatin structure Broadbent et al. 2015) . However, other regions of the genome can be found in alternative chromatin states in different individual cells (Fig. 2) . In such regions, known as facultative heterochromatin or bistable chromatin, once one or the other state is established the resulting gene expression patterns are heritable through multiple cell generations, a phenomenon frequently referred to as epigenetic memory. However these states are reversible, thus a gene that is silenced for many generations can once again revert to the active state, and vice versa. Herein lies the mechanistic basis for clonally variant expression and the biological phenomena described above.
Progression through the different stages of the asexual cycle of P. falciparum requires a tightly regulated cascade of gene expression in which most of the ~5300 genes display a narrowly defined timing of activation (Bozdech et al. 2003; Le Roch et al. 2003) . The general chromatin structure of the genome as a whole similarly displays cyclical, dynamic changes. The density of nucleosomes along the length of the chromosomes, called nucleosome occupancy, is somewhat depleted as cells enter S-phase in the trophozoite stage, then becomes maximal in schizonts (Bunnik et al. 2014) . Nucleosomes also appear to be clearly positioned around transcriptional landmark sites, including transcription start sites, regulatory elements and splice donor and acceptor sites (Kensche et al. 2016) . Euchromatic transcript levels, and their incorporation into the chromatin at specific regions of the genome appears to depend on the underlying DNA sequence ).
All of these dynamic chromatin changes that occur over the course of the asexual cycle within constitutively euchromatic regions of the genome are unlikely to carry heritable information ), but together they contribute to the cascade of gene activation that enables the parasites to faithfully complete each round of schizogony. Special chromatin also forms at centromeres, including the incorporation of the variant histone cenH3. The centromeres from the different chromosomes cluster together within the nucleus during mitosis and cytokinesis, but dissociate after the merozoites re-invade erythrocytes and reinitiate a new cycle (Hoeijmakers et al. 2012) . Additionally, DNA methylation has also been detected and proposed to contribute to transcriptional regulation (Ponts et al. 2013 ).
General mechanisms regulating clonally variant gene expression
As mentioned above, genes that display clonally variant expression are associated with bistable chromatin, which can be found as either euchromatin or facultative heterochromatin, resulting in either activation or silencing, respectively.
This chromatin state is heritable and thus must be faithfully reproduced as the genome transitions through multiple rounds of replication and division during schizogony. Only relatively rarely does a gene switch transcriptional states, however the ability to switch is key for parasites to be able to display clonally 
Specific mechanisms regulating var gene expression
Of the genes that undergo clonally variant expression, the most work has focused on the var gene family that encodes the variant surface protein PfEMP1.
The haploid genome of any given parasite includes ~60 var genes, which are expressed in a mutually exclusive manner. As described above, the active gene is associated with chromatin that incorporates the H3K9ac modification, while the remaining, silent members of the family are marked by histones carrying H3K9me3. As expected, the silent genes are bound by HP1 and incorporated into heterochromatin that is segregated into the nuclear periphery, where they group together into 5-7 clusters (Freitas-Junior et al. 2000) . Interestingly, the active member of the family is also found at the nuclear periphery, but it is separated from the silent genes into a subnuclear position that also includes the histone methyltransferase PfSET10 Ralph et al. 2005; Volz et al. 2012) . It is postulated that this methyltransferase is responsible for the H3K4me3 modification found at the active var gene ). An additional histone mark that appears to be important for var gene regulation is H3K36me3, a modification incorporated by the methyltransferase PfSET2 (Cui et al. 2008a ) that in model eukaryotes is typically associated with transcriptional elongation. ncRNAs were first identified associated with var genes when this gene family was initially discovered, although their function was not understood (Su et al. 1995) .
These RNAs are transcribed from an RNA pol II promoter found within the conserved intron located within all var genes (Kyes et al. 2007 ). The intron is required for recognition of var genes for mutually exclusive expression (Deitsch et al. 2001; Dzikowski et al. 2007) , and it has been shown to transcribe an antisense ncRNA from the single active gene while producing sense ncRNAs from all members of the family (Jiang et al. 2013; Amit-Avraham et al. 2015) . The role of the ncRNAs themselves is not known, however targeting the antisense transcripts for degradation or over-expression greatly alters var gene expression patterns (Amit- Avraham et al. 2015) , and an RNA exosome was recently identified that appears to be important for controlling antisense ncRNA levels (Zhang et al. 2014 ).
Disruption of the RNAse activity of this exosome strongly affects var gene expression patterns. In addition to the ncRNAs themselves, the RNA pol II complex that transcribes them might also play a direct role in recruiting histone modifiers to var loci. PfSET2, the histone methyltransferase that deposits the H3K36me3 mark at var genes, binds to the C-terminal domain of RNA pol II and thus could be recruited by the polymerase while it is transcribing the sense ncRNAs (Ukaegbu et al. 2014 ). This would explain why both active and silent genes are marked by H3K36me3, and is consistent with the hypothesis that this mark is responsible for genes to be recognized as members of the var gene family. Additional work will begin to decipher how these different aspects of var gene regulation integrate into an overall mechanism of control, and further how mutually exclusive expression and switching are coordinated. Work in the field will also help to determine how var gene switching integrates with selection by the human immune system (Abdi et al. 2016 ), a topic that has not been extensively studied, and also how transmission through the mosquito potentially "resets" the expression patterns of clonally variant gene families (Spence et al. 2015) .
IMPORTANCE OF RESEARCH ON MALARIA EPIGENETICS IN THE CONTEXT OF ERADICATION
The new paradigm in the fight against malaria is eradication. An agenda has been developed to guide the steps that need to be undertaken to achieve this ambitious aim (Alonso et al. 2011) . Considering the low expectations of having a highly effective vaccine available in the next few years, elimination efforts will have to rely mainly on vector control strategies and antimalarial drugs that could be used in mass drug administration schemes. Monitoring and diagnostic tools will also play important roles in elimination campaigns. Research on malaria epigenetics can contribute to the development of new public health tools that could facilitate elimination.
Monitoring malaria phenotypes: genes under epigenetic regulation as markers for virulence and transmission potential
Malaria elimination campaigns will represent an extremely strong selective pressure for malaria parasites, which makes it reasonable to fear that such interventions may result in accelerated parasite evolution. There is a risk that elimination efforts may select for "super-parasites" with undesirable traits such as increased virulence, more efficient transmission, increased resilience in front of low vector availability, increased resistance to multiple drugs, or even an increased ability to generate resistance to new drugs reminiscent of the accelerated resistance to multiple drugs (ARMD) phenotype (Rathod et al. 1997) . Monitoring how parasite traits evolve during elimination campaigns is essential to avoid potentially disastrous consequences of the attempts to eradicate the disease.
Monitoring will be necessary at the epidemiological level, but also at the genetic, phenotypic and epigenetic levels. Strong pressures can obviously result in the selection of genetic variants that confer increased fitness in front of the new challenges, but it is also possible that there is selection of parasites with epigenetic patterns that have an analogous effect. As described above, some parasite traits are associated with the expression of specific clonally variant genes: for example, expression of some var genes is associated with increased risk of severe disease (Jensen et al. 2004; Rottmann et al. 2006; Avril et al. 2012; Claessens et al. 2012; Lavstsen et al. 2012) , and pfap2-g expression levels could be used as a proxy for parasite investment into sexual conversion and transmission. Expression of these genes and several others should be characterized in parasites that persist in settings where elimination efforts are not completely successful and a residual parasite population survives, albeit with altered epidemiology. This could help to understand the adaptive pathways of surviving parasites, as well as to appreciate the potential risks associated with the evolved parasites (e.g. increased virulence), or to identify their Achilles' heels.
Epigenetic regulation of gene expression as a target for therapeutic intervention: "epidrugs"
It is unclear whether existing drugs, used wisely, are sufficient to achieve success in malaria elimination campaigns. In any case, new antimalarial drugs with desirable properties such as being effective against all parasite stages or requiring a single dose, if available, would certainly facilitate the task. In this regard, epigenetic regulators are considered a promising new class of drug targets, with some attractive characteristics described below.
Epigenetic regulation of gene expression is a highly dynamic process, implying that it is possible to alter normal epigenetic states through modulation of the enzymes involved in the process. Interfering pharmacologically with the delicate balance between the alternative epigenetic states of clonally variant genes could compromise parasite survival in several ways (Fig. 3) . First, inhibiting the epigenetic factors that are necessary for var silencing could result in parasites that simultaneously express multiple forms of PfEMP1, inducing the development of broadly reactive immune responses that eliminate the current infection and additionally confer protection against future infections. An analogous strategy to disrupt normal antigenic variation has been successfully applied to induce protective immunity against Giardia lambia in rodent models of disease (Rivero et al. 2010) . Second, altering the balance between the active and silenced states of Orthologs of many known chromatin modifiers have been identified in the P.
falciparum genome (Cui et al. 2008a; Bischoff and Vaquero 2010) . The first obvious targets for antimalarial "epidrug" development are the enzymes that add or remove acetyl or methyl groups from histone tails (Table 2) . Importantly, inhibitors of this type of enzymes have been developed for the fight against other diseases such as cancer, providing a large number of chemical starting points and a wealth of knowledge that could be used for the development of malaria-specific epigenetic inhibitors (Arrowsmith et al. 2012) . Several compounds that were identified as inhibitors of histone deacetylases (HDACs) or acetyltransferases (HATs) in other eukaryotes inhibit P. falciparum growth, and some of them have a more potent effect on malaria parasites than on human cells (Merrick and Duraisingh 2007; Cui et al. 2008b; Andrews et al. 2012a; Andrews et al. 2012b; Duffy et al. 2014 ).
Inhibitors of P. falciparum lysine methyl-transferases (KMTs) have also been identified and shown to effectively kill malaria parasites of different species and at different stages of development (Malmquist et al. 2012; Malmquist et al. 2015) .
Furthermore, a sublethal concentration of one such compound, chaetocin, was recently shown to alter the epigenetic regulation of var gene expression by increasing the frequency of expression switches in this gene family (Ukaegbu et al. 2015) . Interestingly, another KMT inhibitor was shown to activate dormant liver forms called hypnozoites (Dembele et al. 2014) , which are produced by some malaria parasite species including P. vivax and are considered one of the less accessible malaria infection reservoirs. This observation raises the intriguing possibility that hypnozoite activation may be regulated at the epigenetic level. If this is the case, it may be possible to target these highly resilient forms with epigenetic drugs.
FUTURE PERSPECTIVES
Epigenetics continues to be a vibrant field of investigation in all eukaryotic systems, from animals to plants to protozoans. Given their somewhat "stripped down" repertoire of transcription factors, it is likely to play an even bigger role in the biology of malaria parasites. With the development of drugs that target epigenetic factors as therapies for human diseases like autoimmune disorders or cancer, this rapidly evolving technology can be applied to the development of antimalarial compounds that kill parasites, reduce virulence and disrupt transmission, all key components of any elimination/eradication campaign. Along the way these compounds will also serve as tools for investigating the basic biology of these evolutionary distant and fascinating organisms. The recent development of new technologies for genetic manipulation of the parasites, including powerful methods for genome editing, will also contribute to addressing some of the burning questions in the malaria epigenetics field described in this chapter. Considering that epigenetics often studies properties that vary from one cell to another, it will be important to also develop improved technologies for analysis at the single-cell level, which could bring enormous progress to the field.
CONCLUDING REMARKS
It is exciting to once again consider the prospects of malaria elimination and eradication after such plans were previously abandoned decades ago. Recent gains in reducing the global malaria burden provide tantalizing hope that elimination is indeed possible. Nonetheless, for progress against the disease to be sustained, new intervention strategies will be required as drug and insecticide resistance inevitably arise. As funds and resources are devoted to disease reduction in the field, it will be important not to neglect basic research into the fundamental biology of the parasite and its mosquito vector. It is this discovery process that will yield the drugs, vaccines and intervention strategies of the future that will be required for the ultimate eradication of malaria. Epigenetics is one such field that is rapidly developing and likely to be a rich source of novel targets for antimalaria strategies.
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